Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mitochondrial ATP-sensitive potassium channel (mitoKATP) is a potassium-selective ion channel located in the inner mitochondrial membrane. It acts as a metabolic sensor, coupling the energetic state of the cell to mitochondrial function by regulating potassium flux in response to intracellular levels of ATP and ADP. It is composed of MITOK (pore-forming) and MITOSUR (regulatory) subunits. The channel opens or closes depending on the cellular ATP/ADP ratio, with high ATP inhibiting and low ATP/high ADP activating the channel. Physiologically, it regulates mitochondrial volume, maintains membrane potential, and provides cytoprotection. Dysfunction is implicated in various diseases involving metabolic stress or ischemic injury. It is pharmacologically modulated by openers like diazoxide and pinacidil, and inhibitors like sulfonylureas.
Openers (e.g., diazoxide, pinacidil) activate the mitoKATP channel, increasing K+ influx into the mitochondria. Inhibitors (e.g., sulfonylureas like glibenclamide) block the channel, preventing K+ influx.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP-Sensitive Potassium Channel (Mitochondrial) (mitoKATP).